Scientific Committee

  • Dr. Ignacio Luque

    Spanish National Research Council

    Dr. Ignacio Luque received his PhD degree in Biochemistry from the University of Seville (Spain) in 1995 and moved for postdoctoral stays at UMDNJ (New Jersey, USA) and the Pasteur Institute (Paris, France). He is now a Research Scientist at the Spanish National Research Council. Dr. Luque is interested in the evolution of aminoacyl-tRNA synthetases and their functional expansion. 

  • Dr. Leslie Nangle

    aTyr Pharma

    Dr. Nangle has over nine years experience in research dedicated to the elucidation of non-canonical functions of AARS. She received her Ph. D. in the laboratory of Paul Schimmel at the Scripps Research Institute, with seven publications on original research involving the aminoacyl tRNA synthetases. Dr. Nangle has built the discovery platform ataTyr Pharma and Pangu BioPharma.

  • Dr. Magali Frugier

    IBMC-CNRS, Strasbourg

    M. Frugier has worked for many years on protein synthesis, focusing her attention on aminoacylation reactions. She has also adapted the phage display technique to study protein/RNA interactions and for now, in addition to its interest into Plasmodium translation, she is currently involved in studying the regulation of aminoacyl-tRNA synthetases expression.

  • Prof. Christopher Francklyn

    University of Vermont

    Dr. Christopher Francklyn received his Ph.D from the University of California at Santa Barbara in 1988. From 1989-1991, he carried out postdoctoral studies with Paul Schimmel, then at M.I.T. He joined the University of Vermont in 1991. He is currently Professor in the Department of Biochemistry, and Adjunct Professor in the Department of Microbiology and Molecular Genetics.

  • Prof. Hiroaki Suga

    The University of Tokyo

    Hiroaki Suga is a Professor of the Department of Chemistry, Graduate School of Science in the University of Tokyo. He was born in Okayama City, Japan in 1963. His research interests are in the field of bioorganic chemistry, chemical biology and biotechnology related to RNA, translation, and peptides.

  • Prof. Michael Ibba

    The Ohio State University

    Michael Ibba is Professor and Director of the Biochemistry Graduate Program at Ohio State University, and a member of the FEBS Letters Editorial Board since 2008. Dr. Ibba's research is directed towards understanding the mechanisms that determine how cells ensure the accurate translation of the genetic code, and how changes in the underlying processes impact cellular health and contribute to microbial pathogenesis and disease.

  • Prof. Min Guo

    The Scripps Research Institute

    Min Guo is a professor in the Department of Cancer Biology at the Scripps Research Institute. Guo received his bachelor's degree in Biology and his Ph.D. in Structural Biology from the University of Science and Technology of China (Hefei, People's Republic of China), before his postdoctoral work in the Schimmel-Yang lab. His research is focused on the functional interactions of aminoacyl-transfer RNA synthetases.

  • Prof. Sung-Hoon Kim

    Seoul National University

    Dr. Sunghoon Kim is a Professor at the Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Korea. He has been studying novel functions of human aminoacyl-tRNA synthetases (ARSs) and searching for their pathophysiological connections to human diseases. His research is unveiling novel regulatory network mediated by human aminoacyl-tRNA synthetases that have been regarded as housekeeping machinery for protein synthesis.

  • Prof. Susan A. Martinis

    University of Illinois

    Dr. Susan Martinis, is a Professor and Chair, at the University of Illinois, Departments of Biochemistry and Medical Biochemistry. She received her BS Ph.D. from the University of Illinois in 1990 and her Postdoc. at the Massachusetts Institute of Technology. Her research topics include Enzymology, Molecular Evolution, Protein-Nucleic Acid Interactions, RNA Biology.

  • Prof. Xianglei Yang

    The Scripps Research Institute

    Prof Xiang-Lei Yang received her BS in Biomedical Engineering from Capital Institute of Medical Science (Beijing), and her PhD in Biophysics and Computational Biology from University of Illinois at Urbana-Champaign. She was previously a postdoctoral fellow, Assistant Professor and Associate Professor at The Scripps Research Institute. She is currently Professor of Chemical Physiology at The Scripps Research Institute.